Corrigendum: Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression.

[This corrects the article DOI: 10.3389/fnins.2023.

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression.

Drug-resistant mental disorders, particularly treatment-resistant depression, pose a significant medical and social problem. To address this challenge, modern psychiatry is constantly exploring the use of novel treatment methods, including biological treatments, such as transcranial magnetic stimulation (TMS), and novel rapid-acting antidepressants, such as ketamine. While both TMS and ketamine demonstrate high effectiveness in reducing the severity of depressive symptoms, some patients still do not achieve the desired improvement.